TRANSLATE

Tuesday, 21 May 2013

WHAT IS THE MOST SERIOUS AND FREQUENT COMPLICATION OF PATIENTS RECEIVING CHEMOTHERAPY?


Answer: Febrile neutropenia.

The word febrile means you have a fever.  A fever is defined as a single oral temperature of greater than or equal to 38.3°C (101 F), or a temperature of greater than 38.0°C (101.4 F) lasting at least an hour. NOTE: Patient may not present with fever, but may have symptoms such as hypotension, tachycardia or chills. Fever neutropenia occurs when a patient has a fever and a significant reduction in their white blood cells (neutropenia) that are needed to fight infections. Many patients when undergoing cancer treatment will have a reduction in their white blood cells that may be temporary or may persist for some time. The fever may be caused by an infectious agent, and when it is rapid treatment is required. A patient with febrile neutropenia needs assessment for the possible source and type of infection and treatment until the cause is found or it subsides.

What you should do if you have any of these signs?
Sometimes it is hard to tell if you have an infection. However, if you have any warning signs and your white blood cells count may be low, this is a medical emergency. Even if you feel fairly well, you must contact your doctor or nurse or go to your nearest hospital Emergency Room immediately!
What could happen if the physician confirms that you have a febrile neutropenia?
The first decision of the physician will be to hold the chemotherapy treatment. If the patient has febrile neutropenia then cultures and more blood tests will be taken to try to determine the presence and possible site of any infections. A decision will have to be made by the physician as to whether the patient should be admitted to a health care facility for observation and treatment. This decision will be based on the clinical state of the patient and the predicted length of the lowered white blood cell counts. Whether the patient is admitted or not treatment will usually include the use of antibiotics. Be aware that you physician may prescribe you the colony-stimulating factors (CSFs), which are glycoproteins that stimulate a fast repopulation of the white blood cells, for a faster control of the infection or febrile neutropenia .
What are the risks to develop a febrile neutropenia?
In addition to the risk of the chemotherapy treatment and the specific malignancy being treated, the following factors need to be considered when evaluating a patient’s overall risk for febrile neutropenia: Older patient, previous chemotherapy and radiotherapy, preexisting neutropenia or bone marrow dysfunction due to tumor involvement, poor performance status and poor renal and liver function.  If you are in one of such group of risk, your physician will recommend the use of CSF prophylactically in each cycle of treatment.
Luis Mendoza, MD, PHD

No comments:

Post a Comment